Supplementary Figure 6
PfPKG is not part of the high molecular weight PfCDPK1 complex but exists as monomer.
Parasite lysate (300l, approx. 1mg total protein) was fractionated over a Wild type parasites were treated with vehicle or Compound 2 (2 M, 60 mins), lysed, trypically digested and the peptides labelled with isobaric tags before the phospho-peptides were enriched. The peptides were then analysed by mass spectrometry and the distribution curves representing changes in the abundance of the peptides plotted. Those phospho-peptides that were seen to be present in the lower quartile of the distribution curves in all three experiments were then compared with the same peptides present in the three global phosphoproteomic experiments conducted on the PKG T618Q mutant 10 parasites. Those phosphopeptides that were seen to be reduced in both the wild type and mutant parasites were considered to represent the off-target action of Compound 2 and those peptides that were only seen to be reduced in the wild type parasites were the on-target action of Compound 2 and therefore considered as cellular targets for PfPKG.
Supplementary Table 1
List of PCR primers used in this study.
